Palliative treatment of malignant breast neoplasms in postmenopausal women
Adult: 10-20 mg daily.
Oral
Advanced prostatic carcinoma
Adult: 1-3 mg daily.
Vaginal
Menopausal atrophic vaginitis
Adult: 1 mg daily as pessaries.
Chỉ định và Liều dùng
Oral
Palliative treatment of malignant breast neoplasms in postmenopausal women Adult: 10-20 mg daily. Oral Advanced prostatic carcinoma Adult: 1-3 mg daily. Vaginal Menopausal atrophic vaginitis Adult: 1 mg daily as pessaries.
|
Suy thận
Use with caution.
|
Suy gan
Use with caution.
|
Chống chỉ định
Pregnancy, thromboembolic disease, porphyria; breast cancer (with exceptions).
|
Thận trọng
CV disease; hepatic and renal impairment.
|
Tác dụng không mong muốn
GI disturbances, CV and CNS side effects, jaundice, impotence. Feminization, impotence and gynaecomastia in men. Withdrawal and breakthrough bleeding, irregular menses, amenorrhoea in women. Hypercalcaemia, chloasma, keratoconus, contact lenses intolerance, altered carbohydrate metabolism, loss of diabetic control.
|
Tương tác
Anticoagulants, liver enzyme inducers, corticosteroids.
|
Ảnh hưởng đến kết quả xét nghiệm
Elevated liver function tests.
|
Tác dụng
Description:
Mechanism of Action: Diethylstilbestrol is a synthetic nonsteroidal oestrogen with effects similar to natural oestrogens. It inhibits luteinising hormone secretion by the pituitary, thereby inhibiting testosterone secretion. Pharmacokinetics: Absorption: Readily absorbed from the GI tract. Metabolism: Slowly metabolised in the liver. Excretion: Excreted in the urine and faeces, mainly as the glucuronide. |
Phân loại MIMS
|